A recent Phase III trial has kicked off to investigate the performance of a cutting-edge antibiotic called Drug Z in the management of common bladder issues. The trial is being conducted at multiple sites across the world and will enroll thousands of patients with different types of UTIs. Researchers are hopeful that Compound X show significant imp